However, radiotherapy of patients with vulvar cancer (dark orange dots) as well as CRT of patients with cervical cancer (dark blue and red dots) significantly increased frequencies of CD133 resulting in 86-89% CD133+ CTCs. This evidence concerns the gene PROM1 and cervical carcinoma.